TL;DR: Diabetes and depression form a vicious cycle: high blood sugar triggers neuroinflammation and HPA axis dysfunction that cause depression, while depression sabotages blood sugar control through behavioral and metabolic pathways. Doctors have known for years that depression and type 2 diabetes often occur together. A patient in the clinic with uncontrolled blood sugar frequently …
CYP2C19 poor metabolizers showed a nominally higher antidepressant remission rate compared to normal metabolizers, but overall genetic variations in CYP2C19 and CYP2D6 were not significantly associated with antidepressant response. Highlights: Higher Remission Rate: CYP2C19 poor metabolizers had a nominally higher remission rate (OR = 1.46) compared to normal metabolizers, but this did not hold after …
Antidepressant treatment in OCD is linked to structural and functional brain changes, particularly in corticosubcortical areas, but these findings need further validation in larger, more homogeneous samples. Highlights: Antidepressant Use: Antidepressants, especially SSRIs, are a primary treatment for OCD, resulting in significant brain changes. Brain Structure Changes: Studies show volume alterations in the thalamus, amygdala, …
Cancer patients frequently experience depressive symptoms, and the role of serotonin in tumor regulation varies across different types. Highlights: Prevalence of Depression in Cancer Patients: A significant portion of cancer patients experience depressive symptoms, which are often linked to neuroendocrine hormone imbalances and decreased serotonin levels. Neuroimmunology’s Role: Neuroimmunology is an emerging field that has …
Antidepressant use has risen steadily for 30 years. Over 10% of adults in England now take them long-term, but evidence suggests up to half lack clear medical justification to continue. Patients and doctors are reluctant to stop treatment due to fears of relapse and withdrawal effects. Research indicates more proactive treatment review, slower drug tapering …
Depression often comes with significant sleep disturbances that can persist even after other symptoms improve. Choosing an antidepressant that alleviates sleep problems may improve outcomes. Key Facts: Sleep complaints like insomnia occur in 60-90% of depression patients. Poor sleep is associated with higher suicide risk. Sedative antidepressants like mirtazapine quickly improve sleep, while SSRIs/SNRIs may …
The presence of pharmaceuticals in the environment has become a growing concern, with increasing evidence that these compounds can impact wildlife at low, environmentally relevant levels. One drug in particular – the popular antidepressant fluoxetine (Prozac) – deserves special attention due to its potential effects on brain function and behavior. Key Facts: Fluoxetine is commonly …
Brain zaps are brief, electric shock-like sensations felt in the brain that can occur when decreasing or stopping dosage of certain antidepressants. Though poorly understood, new research is shedding light on this perplexing phenomenon. Key Facts: Brain zaps are a recently acknowledged potential side effect of discontinuing certain antidepressants like SSRIs and SNRIs. They feel …
A new study published in the journal Mædica – a Journal of Clinical Medicine compared the antidepressant effects of modafinil versus citalopram for treating major depressive disorder (MDD). The medications were equally effective at reducing depressive symptoms over a 6-week treatment period. Key facts: 30 patients with MDD were treated with either modafinil or citalopram …
A new brain imaging study provides insight into how antidepressants like selective serotonin reuptake inhibitors (SSRIs) may bring about symptom improvement in adolescents with major depressive disorder. The findings suggest that changes in a brain region involved in cognitive control may serve as markers of treatment response. Key Facts: Researchers used MRI scans to examine …
